Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B – a prospective cohort study with paired transient elastography examinations
Alimentary Pharmacology & Therapeutics2014Vol. 39(8), pp. 883–893
Citations Over TimeTop 10% of 2014 papers
Grace Lai–Hung Wong, Henry Lik‐Yuen Chan, Zhuo Yu, Anthony W.H. Chan, Paul Cheung‐Lung Choi, A. M.‐L. Chim, Hoi–Yun Chan, Chi‐Hang Tse, Vincent Wai‐Sun Wong
Abstract
Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B infection, independent of viral load and hepatitis activity.
Related Papers
- → Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease(2017)30 cited
- → Prevalence of fatty liver in metabolic syndrome(2020)16 cited
- → Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?(2008)17 cited
- Prevalence survey on fatty liver and metabolic syndrome(2009)
- Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease(2019)